Targeting Obesity to Treat Heart Failure - With Preserved Ejection Fraction (HFpEF)
Om avsnittet
Watch the full video on YouTube to explore the latest insights into heart failure with preserved ejection fraction (HFpEF) and the impact of GLP-1 receptor agonists. Discover how weight loss and metabolic therapies could transform treatment for people with diabetes, obesity, and heart failure.
You can also watch the full session from the EASD Annual Meeting 2024 for more insights into cardiovascular health, diabetes management, and obesity care.
Delve deeper into the professional portrait of our speakers; Melanie Davies, Mark Petrie and Mikhail Kosiborod
Diabetes Insights - Breakthroughs and Innovators med EASD - European Association for the Study of Diabetes finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.